landmark 发表于 2025-3-25 03:54:35

http://reply.papertrans.cn/3/223/22272/22272-21.png

overreach 发表于 2025-3-25 09:29:12

Submitted on: 21 November 2006.
Revised on: 18 December 2006.
Accepted on: 28 December 2006.
MOLECULAR PHARMACEUTICS---AMER CHEMICAL SOC

懒惰人民 发表于 2025-3-25 14:26:46

http://reply.papertrans.cn/3/223/22272/22272-23.png

错事 发表于 2025-3-25 16:37:45

http://reply.papertrans.cn/3/223/22272/22272-24.png

忍耐 发表于 2025-3-25 21:46:46

http://reply.papertrans.cn/3/223/22272/22272-25.png

取回 发表于 2025-3-26 00:44:07

http://reply.papertrans.cn/3/223/22272/22272-26.png

inventory 发表于 2025-3-26 07:27:04

http://reply.papertrans.cn/3/223/22272/22272-27.png

Brocas-Area 发表于 2025-3-26 11:24:43

Submitted on: 18 January 2011.
Revised on: 14 February 2011.
Accepted on: 01 March 2011.
MOLECULAR PHARMACEUTICS

维持 发表于 2025-3-26 16:06:22

Submitted on: 04 August 1998.
Revised on: 10 September 1998.
Accepted on: 03 October 1998.
MOLECULAR PHARMACEUTICS---AMER CHEMICAL SOC

停止偿付 发表于 2025-3-26 17:38:46

http://reply.papertrans.cn/3/223/22272/22272-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊MOLECULAR PHARMACEUTICS 2024/2025影响因子:4.515 (MOL PHARMACEUT) (1543-8384). (PHARMACOLOGY & PHARMACY)(药理学与药学)Scienc